Advertisement
Screener

KYNTRA BIO, INC. (KYNB) Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

1.8 / 5 stars · 34/94 Roast Me

KYNTRA BIO, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

KYNTRA BIO, INC. (KYNB) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $407.49 million as of 2019-12-31, per its 10-K filed 2020-03-02.

Discontinued › Notes › Investments

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2020-03-02

  • 2019-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $407.49M.
  • 2018-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $532.14M.
  • 2017-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $53.94M.
  • 2016-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $67.08M.
Period endDebt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
2019-12-31$407.49M
10-K · filed 2020-03-02
2018-12-31$532.14M
10-K · filed 2019-02-27
2017-12-31$53.94M
10-K · filed 2018-02-27
2016-12-31$67.08M
10-K · filed 2017-03-01
2015-12-31$12.80M
10-K · filed 2016-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13